Increases In Erythropoiesis Stimulating Agent (Esa) Use After Hospitalization Of End Stage Renal Disease (Esrd) Patients
Hemodialysis (HD) patients are frequently hospitalized. Interruption of normal dialysis and 3x/weekly ESA treatments, along with the cause of hospitalization, normally leads to declines in Hb and increased ESA utilization post-hospitalization. In this retrospective analysis, we examined Hb levels an...
Saved in:
Main Authors: | T. Christopher Bond (Author), Steven Wang (Author), Jaime Rubin (Author), Alex Yang (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ErythropoieSIS stimulating agent (ESA) use is increased following missed dialysis sessions
by: T. Christopher Bond, et al.
Published: (2012) -
ESRD POST-HOSPITALIZATION ANEMIA AND ESA UTILIZATION
by: Alex Yang, et al.
Published: (2012) -
Erythropoiesis‐stimulating agents and incident malignancy in chronic kidney and end‐stage renal disease: A population‐based study
by: Yu‐Shan Huang, et al.
Published: (2022) -
Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
by: Patrick Biggar, et al.
Published: (2017) -
Recent Advances in the Management of End-Stage Renal Disease (ESRD) in Children
by: Richard N. Fine
Published: (2019)